GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biodexa Pharmaceuticals Plc (NAS:BDRX) » Definitions » Price-to-Tangible-Book

Biodexa Pharmaceuticals (Biodexa Pharmaceuticals) Price-to-Tangible-Book : 1.79 (As of May. 01, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Biodexa Pharmaceuticals Price-to-Tangible-Book?

As of today (2024-05-01), Biodexa Pharmaceuticals's share price is $1.32. Biodexa Pharmaceuticals's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $0.74. Hence, Biodexa Pharmaceuticals's Price to Tangible Book Ratio of today is 1.79.

The historical rank and industry rank for Biodexa Pharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:

BDRX' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.79   Med: 2.49   Max: 10.5
Current: 1.91

During the past 11 years, Biodexa Pharmaceuticals's highest Price to Tangible Book Ratio was 10.50. The lowest was 0.79. And the median was 2.49.

BDRX's Price-to-Tangible-Book is ranked better than
56.18% of 1221 companies
in the Biotechnology industry
Industry Median: 2.69 vs BDRX: 1.91

A closely related ratio is called PB Ratio. As of today, Biodexa Pharmaceuticals's share price is $1.32. Biodexa Pharmaceuticals's Book Value per Sharefor the quarter that ended in Dec. 2023 was $1.99. Hence, Biodexa Pharmaceuticals's P/B Ratio of today is 0.66.


Biodexa Pharmaceuticals Price-to-Tangible-Book Historical Data

The historical data trend for Biodexa Pharmaceuticals's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biodexa Pharmaceuticals Price-to-Tangible-Book Chart

Biodexa Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.72 2.61 1.49 1.11 3.63

Biodexa Pharmaceuticals Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.49 1.15 1.11 0.57 3.63

Competitive Comparison of Biodexa Pharmaceuticals's Price-to-Tangible-Book

For the Biotechnology subindustry, Biodexa Pharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biodexa Pharmaceuticals's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biodexa Pharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Biodexa Pharmaceuticals's Price-to-Tangible-Book falls into.



Biodexa Pharmaceuticals Price-to-Tangible-Book Calculation

Biodexa Pharmaceuticals's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=1.32/0.739
=1.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Biodexa Pharmaceuticals Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Biodexa Pharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Biodexa Pharmaceuticals (Biodexa Pharmaceuticals) Business Description

Traded in Other Exchanges
Address
1 Caspian Point, Caspian Way, Cardiff, GBR, CF10 4DQ
Biodexa Pharmaceuticals Plc is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and development medications with its proprietary and innovative drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.